Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain

Journal of Lipid Research

Volumn 49, Issue 9, 2008, Pages 1990-2000

  Farias, Santiago E ^a   Basselin, Mireille ^b   Chang, Lisa ^b   Heidenreich, Kim A ^a   Rapoport, Stanley I ^b   Murphy, Robert C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arachidonic; Brain ischemia; Docosahexaenoic; Docosanoids; Eicosanoids; Isoprostanes

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 5 OXO EICOSATETRAENOIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSANOID; LIPOXYGENASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; THROMBOXANE B2; UNCLASSIFIED DRUG; ISOPROSTANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DECAPITATION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEFT HEMISPHERE; LIPID BRAIN LEVEL; MICROWAVE IRRADIATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; RIGHT HEMISPHERE; TANDEM MASS SPECTROMETRY; ANIMAL; BIOSYNTHESIS; BRAIN; BRAIN LEVEL; FISCHER 344 RAT; MALE; METABOLISM; MICROWAVE RADIATION; RADIATION EXPOSURE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; BRAIN ISCHEMIA; DECAPITATION; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; EICOSANOIDS; ISOPROSTANES; MALE; MICROWAVES; PROSTAGLANDIN D2; RATS; RATS, INBRED F344;

EID: 53149120665     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800200-JLR200     Document Type: Article

References (61)

1. Raichle, M. E. 1983. The pathophysiology of brain ischemia. Ann. Neurol. 13: 2-10.
2. Farooqui, A. A., and L. A. Horrocks. 2006. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist. 12: 245-260.
3. Adibhatla, R. M., and J. F. Hatcher. 2006. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40: 376-387.
4. Phillis, J. W., and M. H. O'Regan. 2003. The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit. Rev. Neurobiol. 15: 61-90.
5. Rapoport, S. I. 2003. In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J. Pediatr. 143 (Suppl.): 26-34.
6. Sun, G. Y., and R. A. MacQuarrie. 1989. Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N. Y. Acad. Sci. 559: 37-55.
7. Aktan, S., C. Aykut, S. Oktay, B. Yegen, E. Keles, I. Aykac, and S. Ercan. 1991. The alterations of leukotriene C4 and prostaglandin E2 levels following different ischemic periods in rat brain tissue. Prostaglandins Leukot. Essent. Fatty Acids. 42: 67-71.
8. Anton, R. F., C.Wallis, and C. L. Randall. 1983. In vivo regional levels of PGE and thromboxane inmouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins. 26: 421-429.
9. Bosisio, E., C. Galli, G. Galli, S. Nicosia, C. Spagnuolo, and L. Tosi. 1976. Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins. 11: 773-781.
10. Moskowitz, M. A., K. J. Kiwak, K. Hekimian, and L. Levine. 1984. Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science. 224: 886-889.
11. Petroni, A., A. Bertazzo, S. Sarti, and C. Galli. 1989. Accumulation of arachidonic acid cyclo- and lipoxygenase products in rat brain during ischemia and reperfusion: effects of treatment with GM1-lactone. J. Neurochem. 53: 747-752.
12. Petroni, A., A. Socini, M. Blasevich, A. Borghi, and C. Galli. 1985. Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain. Prostaglandins. 29: 579-587.
13. Poddubiuk, Z. M., J. B. Blumberg, and I. J. Kopin. 1982. Brain prostaglandin content in rats sacrificed by decapitation vs focused microwave irradiation. Experientia. 38: 987-988.
14. Rao, A. M., J. F. Hatcher, M. S. Kindy, and R. J. Dempsey. 1999. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem. Res. 24: 1225-1232.
15. Usui, M., T. Asano, and K. Takakura. 1987. Identification and quantitative analysis of hydroxy-eicosatetraenoic acids in rat brains exposed to regional ischemia. Stroke. 18: 490-494.
16. Golovko, M. Y., and E. J. Murphy. 2008. An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J. Lipid Res. 49: 893-902.
17. Peters, O., T. Back, U. Lindauer, C. Busch, D. Megow, J. Dreier, and U. Dirnagl. 1998. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18: 196-205.
18. Morrow, J. D., and L. J. Roberts II. 1994. Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol. 233: 163-174.
19. Morrow, J. D., L. J.Roberts, V. C. Daniel, J. A. Awad, O. Mirochnitchenko, L. L. Swift, and R. F. Burk. 1998. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo - effects of oxygen tension and glutathione. Arch. Biochem. Biophys. 353: 160-171.
20. Milne, G. L., S. C. Sanchez, E. S. Musiek, and J. D. Morrow. 2007. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protocols. 2: 221-226.
21. Marin, J. G., S. Cornet, B. Spinnewyn, C. Demerle-Pallardy, M. Auguet, and P. E. Chabrier. 2000. BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures. Neuroreport. 11: 1357-1360.
22. Hong, S., K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278: 14677-14687.
23. Hong, S., E. Tjonahen, E. L. Morgan, Y. Lu, C. N. Serhan, and A. F. Rowley. 2005. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 78: 107-116.
24. Marcheselli, V. L., S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, et al. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278: 43807-43817.
25. Mukherjee, P. K., V. L. Marcheselli, C. N. Serhan, and N. G. Bazan. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 101: 8491-8496.
26. Schwab, J. M., N. Chiang, M. Arita, and C. N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 447: 869-874.
27. Serhan, C. N. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25: 101-137.
28. Cenedella, R. J., C. Galli, and R. Paoletti. 1975. Brain free fatty levels in rats sacrificed by decapitation versus focused microwave irradiation. Lipids. 10: 290-293.
29. Deutsch, J., S. I. Rapoport, and A. D. Purdon. 1997. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22: 759-765.
30. Bazinet, R. P., H. J. Lee, C. C. Felder, A. C. Porter, S. I. Rapoport, and T. A. Rosenberger. 2005. Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30: 597-601.
31. Deutsch, J., S. I. Rapoport, and T. A. Rosenberger. 2002. Coenzyme A and short-chain acyl-CoA species in control and ischemic rat brain. Neurochem. Res. 27: 1577-1582.
32. Hall, L. M., and R. C. Murphy. 1998. Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom. 9: 527-532.
33. Williams, L. R., H. L.Vahlsing, T. Lindamood, S. Varon, F. H. Gage, and M. Manthorpe. 1987. A small-gauge cannula device for continuous infusion of exogenous agents into the brain. Exp. Neurol. 95: 743-754.
34. Guidotti, A., D. L. Cheney, M. Trabucchi, M. Doteuchi, and C. Wang. 1974. Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology. 13: 1115-1122.
35. Merritt, J. H., and J. W. Frazer. 1977. Microwave fixation of brain tissue as a neurochemical technique - a review. J. Microw. Power. 12: 133-139.
36. Narumiya, S., T. Ogorochi, K. Nakao, and O. Hayaishi. 1982. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31: 2093-2103.
37. Pediconi, M. F., and E. B. Rodriguez de Turco. 1984. Free fatty acid content and release kinetics as manifestations of cerebral lateralization in mouse brain. J. Neurochem. 43: 1-7.
38. Yasuda, H., K. Kishiro, N. Izumi, and M. Nakanishi. 1985. Biphasic liberation of arachidonic and stearic acids during cerebral ischemia. J. Neurochem. 45: 168-172.
39. Rehncrona, S., J. Folbergrova, D. S. Smith, and B. K. Siesjo. 1980. Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J. Neurochem. 34: 477-486.
40. Reich, E. E., W. R. Markesbery, L. J. Roberts 2nd, L. L. Swift, J. D. Morrow, and T. J. Montine. 2001. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer 's disease. Am. J. Pathol. 158: 293-297.
41. Demar, J. C., Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2005. Alpha-linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94: 1063-1076.
42. Igarashi, M., J. C. Demar, Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport. 2007. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48: 1150-1158.
43. Rehncrona, S., E. Westerberg, B. Akesson, and B. K. Siesjo. 1982. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J. Neurochem. 38: 84-93.
44. Yoshida, S., M. Ikeda, R. Busto, M. Santiso, E. Martinez, and M. D. Ginsberg. 1986. Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J. Neurochem. 47: 744-757.
45. Yue, H., S. A. Jansen, K. I. Strauss, M. R. Borenstein, M. F. Barbe, L. J. Rossi, and E. Murphy. 2007. A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue. J. Pharm. Biomed. Anal. 43: 1122-1134.
46. Ikeda, M., S. Yoshida, R. Busto, M. Santiso, and M. D. Ginsberg. 1986. Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J. Neurochem. 47: 123-132.
47. Sun, G. Y., F. L. Lu, S. E. Lin, and M. R. Ko. 1992. Decapitation ischemia-induced release of free fatty acids in mouse brain. Relationship with diacylglycerols and lysophospholipids. Mol. Chem. Neuropathol. 1: 39-50.
48. Chang, M. C., J. M. Bell, A. D. Purdon, E. G. Chikhale, and E. Grange. 1999. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem. Res. 24: 399-406.
49. Williams, W. M., T. Hayakawa, E. Grange, and S. I. Rapoport. 1998. Arecoline stimulation of radiolabeled arachidonate incorporation from plasma into brain microvessels of awake rat. Neurochem. Res. 23: 551-555.
50. Erlemann, K. R., C. Cossette, G. E. Grant, G. J. Lee, P. Patel, J. Rokach, and W. S. Powell. 2007. Regulation of 5-hydroxyeicosanoid dehydrogenase activity in monocytic cells. Biochem. J. 403: 157-165.
51. Powell, W. S., F. Gravelle, and S. Gravel. 1992. Metabolism of 5(S)-hydroxy-6, 8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J. Biol. Chem. 267: 19233-19241.
52. Zarini, S., and R. C. Murphy. 2003. Biosynthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid from 5-hydroperoxyeicosatetraenoic acid in the murine macrophage. J. Biol. Chem. 278: 11190-11196.
53. Choi, J. S., H. Y. Kim, M. H. Chun, J. W. Chung, and M. Y. Lee. 2006. Differential regulation of cyclooxygenase-2 in the rat hippocampus after cerebral ischemia and ischemic tolerance. Neurosci. Lett. 393: 231-236.
54. Kaufmann, W. E., P. F. Worley, J. Pegg, M. Bremer, and P. Isakson. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 93: 2317-2321.
55. Nogawa, S., F. Zhang, M. E. Ross, and C. Iadecola. 1997. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17: 2746-2755.
56. Palluy, O., M. Bendani, J. M. Vallat, and M. Rigaud. 1994. 12-Lipoxygenase mRNA expression by cultured neurons. C. R Acad. Sci. III. 317: 813-818.
57. van Leyen, K., H. Y. Kim, S. R. Lee, G. Jin, K. Arai, and E. H. Lo. 2006. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke. 37: 3014-3018.
58. Taniura, S., H. Kamitani, T. Watanabe, and T. E. Eling. 2002. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277: 16823-16830.
59. Hong, S., Y. Lu, R. Yang, K. H. Gotlinger, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J. Am. Soc. Mass Spectrom. 18: 128-144.
60. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176: 1848-1859.
61. Phillis, J. W., L. A. Horrocks, and A. A. Farooqui. 2006. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Brain Res. Rev. 52: 201-243.